MHRA starts rolling review of AstraZeneca Plc’s potential COVID-19 vaccine

November 02, 2020 12:48 PM GMT | By Team Kalkine Media

British health regulator Medicines and Healthcare Products Regulatory Agency (MHRA) has started a fast-tracked assessment of AstraZeneca Plc’s (LON:AZN) prospective vaccine for coronavirus.

  • The MHRA will be doing a rolling review of the vaccine, where it can see the clinical data in real-time.
  • In the rolling review, the regulator can also interact with the drug makers and keep a tab on manufacturing processes and trials to expedite the approval process.
  • AstraZeneca is developing its Covid-19 vaccine in collaboration with University of Oxford and is one of the frontrunners developing a prospective vaccine.
  • On 2 November 2020, the stocks of AstraZeneca improved by 1.08% from its previous closing, hovering at around GBX 7,850.00 at 09:37 AM GMT+1.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited, Company No. 12643132 (Kalkine Media, we or us) and is available for personal and non-commercial use only. Kalkine Media is an appointed representative of Kalkine Limited, who is authorized and regulated by the FCA (FRN: 579414). The non-personalised advice given by Kalkine Media through its Content does not in any way endorse or recommend individuals, investment products or services suitable for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a qualified financial planner and/or adviser. No liability is accepted by Kalkine Media or Kalkine Limited and/or any of its employees/officers, for any investment loss, or any other loss or detriment experienced by you for any investment decision, whether consequent to, or in any way related to this Content, the provision of which is a regulated activity. Kalkine Media does not intend to exclude any liability which is not permitted to be excluded under applicable law or regulation. Some of the Content on this website may be sponsored/non-sponsored, as applicable. However, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music/video that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music or video used in the Content unless stated otherwise. The images/music/video that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.


Sponsored Articles


Investing Ideas

Previous Next